Posts

Welcome to the Fritsma Factor, please join our hemostasis discussions.

This question was posed by a participant in the Rutgers University graduate course, CLSC 5123,...
Apr 19, 2017 9:24am
This is from Demetra "Toula" Castillo, Carolinas HealthCare. Can someone please explain to me how...
Apr 18, 2017 11:26am
From Wendy Sutula, Hi, George. We are validating a new vendor's ACA kit. When we perfom patient ACA...
Apr 11, 2017 8:05pm
Here is a note from a new acquaintance, colleague Marjorie (Marj) Montanus: Hello, George. I am the...
Apr 3, 2017 9:08am
Apr 19, 2017 9:24am
This question was posed by a participant in the Rutgers University graduate course, CLSC 5123, Advanced Hematology. Rutgers' Clinical Laboratory Science program, directed by Elaine Keohane, PhD, offers an online masters degree program with advanced coursework that atrracts laboratory supervisors and managers.
1 Comment
Apr 18, 2017 11:26am
This is from Demetra "Toula" Castillo, Carolinas HealthCare. Can someone please explain to me how someone with a bleeding disorder can get a PE ? She has type 2M VWD and takes Stimate for localized bleeds and gets monthly infusions of Humate-P. She also has endometriosis due to the VWD. Her last infusion was 3 weeks ago, but was treated with stimate 8 hours ago.
0 Comments
Apr 11, 2017 8:05pm
From Wendy Sutula, Hi, George. We are validating a new vendor's ACA kit. When we perfom patient ACA tests, the serum samples are frozen at –20 for 2–7 days before tesing. When establishing or validating the reference range for the new vendor's kit, is it acceptable to use serums which have been collected and frozen within two hours of collection at –70 instead of –20, and for periods of time longer than 1 week, or must we adhere to the same storage requirements prior to testing as for the patient samples? I couldn't find a specific reference to address this in the CLSI documents. Thanks so much.
0 Comments
Apr 3, 2017 9:08am
Here is a note from a new acquaintance, colleague Marjorie (Marj) Montanus: Hello, George. I am the new Hematology/Coag instructor in the Idaho State University Medical Laboratory Science program replacing Sonya Nehr-Kenat. We have been using an old case study that describes a "friable, soft clot after 24 hours of incubation at 37°C." Could you explain more about what that term means and what diagnostic info it gives to this case study? Here is the case:
0 Comments